Quest Partners LLC Myriad Genetics Inc Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Quest Partners LLC holds 5,304 shares of MYGN stock, worth $143,048. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,304
Previous 49
10724.49%
Holding current value
$143,048
Previous $1.05 Million
12314.93%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
232Shares Held
92.6MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$409 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$271 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$223 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$148 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$119 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.17B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...